Gil-Nagel, A., Falip, M., Sanchez-Carpintero, R., Abad-Sazatornil, M., Poveda, J., Aibar, J., . . . Gil, A. (2022). The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Citación estilo ChicagoGil-Nagel, A., et al. The Contribution of Fenfluramine to the Treatment of Dravet Syndrome in Spain Through Multi-Criteria Decision Analysis. 2022.
Cita MLAGil-Nagel, A., et al. The Contribution of Fenfluramine to the Treatment of Dravet Syndrome in Spain Through Multi-Criteria Decision Analysis. 2022.
Precaución: Estas citas no son 100% exactas.